MX2009005351A - Compounds useful for treating neurodegenerative disorders. - Google Patents
Compounds useful for treating neurodegenerative disorders.Info
- Publication number
- MX2009005351A MX2009005351A MX2009005351A MX2009005351A MX2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds useful
- neurodegenerative disorders
- treating neurodegenerative
- treating
- lessening
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Pest Control & Pesticides (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2006/044880 WO2008063165A1 (en) | 2006-11-20 | 2006-11-20 | Compounds useful for treating neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009005351A true MX2009005351A (en) | 2009-06-08 |
Family
ID=39429980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009005351A MX2009005351A (en) | 2006-11-20 | 2006-11-20 | Compounds useful for treating neurodegenerative disorders. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2073637A4 (en) |
| JP (1) | JP2010510309A (en) |
| KR (1) | KR20090087075A (en) |
| CN (1) | CN101610673A (en) |
| AU (1) | AU2006350960B2 (en) |
| BR (1) | BRPI0622138A2 (en) |
| CA (1) | CA2670276A1 (en) |
| IL (1) | IL198856A0 (en) |
| MX (1) | MX2009005351A (en) |
| WO (1) | WO2008063165A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI433674B (en) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | Cyclopamine analogs |
| US7990394B2 (en) | 2007-05-25 | 2011-08-02 | Google Inc. | Viewing and navigating within panoramic images, and applications thereof |
| WO2011017551A1 (en) | 2009-08-05 | 2011-02-10 | Infinity Pharmaceuticals, Inc. | Enzymatic transamination of cyclopamine analogs |
| WO2012037217A1 (en) | 2010-09-14 | 2012-03-22 | Infinity Pharmaceuticals, Inc. | Transfer hydrogenation of cyclopamine analogs |
| BR112017026103B1 (en) | 2015-06-04 | 2023-10-03 | Sol-Gel Technologies Ltd | TOPICAL COMPOSITIONS WITH HEDGEHOG INHIBITOR COMPOUND, TOPICAL DELIVERY SYSTEM AND THEIR USES |
| US10217283B2 (en) | 2015-12-17 | 2019-02-26 | Google Llc | Navigation through multidimensional images spaces |
| US10245091B2 (en) | 2015-12-30 | 2019-04-02 | Exsomed Holding Company, Llc | Dip fusion spike screw |
| CN107281206A (en) * | 2016-03-30 | 2017-10-24 | 南京惠宝生物医药有限公司 | Black cohosh root glycosides is preparing the application in preventing and treating senile dementia medicine |
| KR102120376B1 (en) * | 2018-05-28 | 2020-06-09 | 한국과학기술연구원 | Composition for preventing and/or treating a degenerative brain disease comprising as an active ingredient an extract of Cimicifuga dahurica, a fraction thereof, or a compound derived from Cimicifuga dahurica |
| CN109528738A (en) * | 2018-12-24 | 2019-03-29 | 陕西师范大学 | Glycyrrhizic acid promotes the application of Remyelination inhibition neuroinflamation drug in preparation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030060425A1 (en) * | 1998-11-24 | 2003-03-27 | Ahlem Clarence N. | Immune modulation method using steroid compounds |
| GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
| CN100430062C (en) * | 2002-03-15 | 2008-11-05 | 萨马里坦药品公司 | Medicinal composition of neuroprotective spirosterenol |
| CN101223185A (en) * | 2005-05-17 | 2008-07-16 | 萨托里医药公司 | Compounds for the treatment of neurodegenerative disorders |
-
2006
- 2006-11-20 EP EP06838050A patent/EP2073637A4/en not_active Withdrawn
- 2006-11-20 CA CA002670276A patent/CA2670276A1/en not_active Abandoned
- 2006-11-20 CN CNA2006800568742A patent/CN101610673A/en active Pending
- 2006-11-20 WO PCT/US2006/044880 patent/WO2008063165A1/en not_active Ceased
- 2006-11-20 JP JP2009538376A patent/JP2010510309A/en active Pending
- 2006-11-20 AU AU2006350960A patent/AU2006350960B2/en not_active Expired - Fee Related
- 2006-11-20 KR KR1020097012727A patent/KR20090087075A/en not_active Ceased
- 2006-11-20 BR BRPI0622138-6A patent/BRPI0622138A2/en not_active IP Right Cessation
- 2006-11-20 MX MX2009005351A patent/MX2009005351A/en not_active Application Discontinuation
-
2009
- 2009-05-20 IL IL198856A patent/IL198856A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0622138A2 (en) | 2011-12-27 |
| IL198856A0 (en) | 2010-02-17 |
| KR20090087075A (en) | 2009-08-14 |
| CA2670276A1 (en) | 2008-05-29 |
| CN101610673A (en) | 2009-12-23 |
| JP2010510309A (en) | 2010-04-02 |
| AU2006350960B2 (en) | 2013-09-12 |
| EP2073637A4 (en) | 2011-12-28 |
| AU2006350960A1 (en) | 2008-05-29 |
| WO2008063165A1 (en) | 2008-05-29 |
| EP2073637A1 (en) | 2009-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008130449A3 (en) | Modulators of amyloid-beta production | |
| EA200971050A1 (en) | METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND DISORDERS | |
| MXPA05012680A (en) | Novel substituted 3-sulfur indoles. | |
| WO2009127642A3 (en) | Use of lrrk2 inhibitors for neurodegenerative diseases | |
| TW200510303A (en) | Novel compounds | |
| MX2007012374A (en) | Methods and compositions for treatment of cns disorders. | |
| TW200612892A (en) | Novel compounds | |
| WO2007138282A3 (en) | Bi-aryl or aryl-heteroaryl substituted indoles | |
| WO2009025785A3 (en) | Cb2 receptor ligands for the treatment of pain | |
| WO2010075280A3 (en) | Coumarin-based compounds for the treatment of alzheimer's disease and cancer | |
| DE502004003249D1 (en) | (s)-2-n-propylamino-5-hydroxytetralin als d3-agonistisches therapeutikum | |
| ATE543494T1 (en) | GRISEOFULVIN ANALOGS FOR TREATING CANCER BY INHIBITING CENTROSOMAL CLUSTER FORMATION | |
| MX2009003981A (en) | Calcium receptor modulating agents. | |
| MX2012004548A (en) | Novel compositions for preventing and/or treating degenerative disorders of the central nervous system. | |
| EP4327874A3 (en) | 3,6-disubstituted xanthylium salts | |
| TW200745003A (en) | Novel compounds | |
| MX2012010084A (en) | Compounds useful for treating neurodegenerative disorders. | |
| WO2008136863A3 (en) | Synthesis of compounds useful as modulators of amyloid-beta production | |
| EA201001586A1 (en) | COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS | |
| MX2009005351A (en) | Compounds useful for treating neurodegenerative disorders. | |
| PT1778837E (en) | Treatment of neurodegenerative diseases by the use of scd4 inhibitors | |
| MX2007011847A (en) | Pyrimidindione derivatives as prokineticin 2 receptor antagonists. | |
| IL185410A0 (en) | Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of parkinson's disease | |
| TW200642690A (en) | Composition for treating central nervous system disorders | |
| TW200602297A (en) | Sulfonamide compounds for the treatment of neurodegenerative disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |